Zobrazeno 1 - 10
of 1 611
pro vyhledávání: '"H. Lip"'
Autor:
Lee, So-Ryoung, Choi, JungMin, Choi, Eue-Keun, Lee, HuiJin, Han, MinJu, Ahn, Hyo-Jeong, Kwon, Soonil, Lee, Seung-Woo, Han, Kyung-Do, Oh, Seil, Y. H. Lip, Gregory
Publikováno v:
In Diabetes Research and Clinical Practice December 2023 206
Autor:
Bisson, Arnaud, M. Fawzy, Ameenathul, Romiti, Giulio Francesco, Proietti, Marco, Angoulvant, Denis, El-Bouri, Wahbi, Y. H. Lip, Gregory, Fauchier, Laurent
Publikováno v:
In Archives of Cardiovascular Diseases June 2023
Autor:
Ding, Wern Yew, Proietti, Marco, Romiti, Giulio Francesco, Vitolo, Marco, Fawzy, Ameenathul Mazaya, Boriani, Giuseppe, Marin, Francisco, Blomström-Lundqvist, Carina, Potpara, Tatjana S., Fauchier, Laurent, H Lip, Gregory Y.
Publikováno v:
In European Journal of Internal Medicine January 2023 107:60-65
Autor:
Giulio Francesco Romiti, Marco Proietti, Marco Vitolo, Niccolò Bonini, Ameenathul Mazaya Fawzy, Wern Yew Ding, Laurent Fauchier, Francisco Marin, Michael Nabauer, Gheorghe Andrei Dan, Tatjana S. Potpara, Giuseppe Boriani, Gregory Y. H. Lip, on behalf of the ESC-EHRA EORP-AF General Long-Term Registry Investigators
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Clinical complexity is increasingly prevalent among patients with atrial fibrillation (AF). The ‘Atrial fibrillation Better Care’ (ABC) pathway approach has been proposed to streamline a more holistic and integrated approach t
Externí odkaz:
https://doaj.org/article/a8f47e6d20f141bcb20d1cde473a30a1
Autor:
Vethanayagam Antony Sheron, Shivany Shanmugathas, Tiffany E. Gooden, Mahesan Guruparan, Balachandran Kumarendran, Gregory Y. H. Lip, Semira Manaseki-Holland, Krishnarajah Nirantharakumar, Kaneshamoorthy Shribavan, Kumaran Subaschandren, Rashan Haniffa, Rajendra Surenthirakumaran, G. Neil Thomas, Powsiga Uruthirakumar, Sheila Greenfield, Deirdre A. Lane, Abi Beane, NIHR Global Health Research Group on Atrial Fibrillation Management
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Atrial fibrillation (AF) is the most common cardiac arrhythmia that affects 60 million people worldwide. Limited evidence on AF management exists from low- and middle-income countries and none from Sri Lanka. We aimed to investiga
Externí odkaz:
https://doaj.org/article/b4d2e9e739b9442fb97ae38347bb9a58
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Evidence for the relationship between glycated hemoglobin (HbA1c) levels and risk of cardiovascular diseases (CVD) in patients with gout remained sparse and limited. This study aims to explore the associations between HbA1c levels
Externí odkaz:
https://doaj.org/article/8d479c9c8f5147b29e635eb8523bd740
Autor:
Thibaut Galvain, Ruaraidh Hill, Sarah Donegan, Paulo Lisboa, Gregory Y. H. Lip, Gabriela Czanner
Publikováno v:
Systematic Reviews, Vol 11, Iss 1, Pp 1-7 (2022)
Abstract Background Atrial fibrillation affects an estimated 33 million individuals worldwide and is a major cause of stroke, heart failure, and death. Anticoagulants substantially reduce the risk of stroke but are also associated with an increased r
Externí odkaz:
https://doaj.org/article/53823e7fde2e4d7e871e79906642616f
Autor:
Wang-Yang Yang, Gregory Y. H. Lip, Zhi-Jun Sun, Hui Peng, Ameenathul M. Fawzy, Hong-Wei Li, The Cardiovascular Center Beijing Friendship Hospital Database Bank (CBD Bank) study group
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundAn increase in the incidence of atrial fibrillation (AF) during the acute phase of myocardial infarction (AMI) has been observed. But it is still unclear whether the implications of new-onset AF on in-hospital and long-term prognosis are of
Externí odkaz:
https://doaj.org/article/3e38a7f2209b416e9c798e0f60d65ce1
Autor:
Katarzyna Nabrdalik, Karolina Skonieczna-Żydecka, Krzysztof Irlik, Mirela Hendel, Hanna Kwiendacz, Igor Łoniewski, Kornelia Januszkiewicz, Janusz Gumprecht, Gregory Y. H. Lip
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
IntroductionMetformin is the first choice drug in the treatment of type 2 diabetes mellitus but its administration may be linked to gastrointestinal adverse events limiting its use.ObjectivesThe objective of this systematic review and meta-analysis w
Externí odkaz:
https://doaj.org/article/d406ec8fb0954df8b28af24c599d78bb
Publikováno v:
PLoS Medicine, Vol 19, Iss 8, p e1004067 (2022)
In this Perspective, Dimitrios Sagris, Stephanie Harrison, and Gregory Lip discuss new evidence concerning the paradoxical relationship between circulating lipids and atrial fibrillation.
Externí odkaz:
https://doaj.org/article/15d0f26d28284f89a18351f5a2cb105f